← Open Payments lookup

KATE CLARK: Open Payments

NPI 1780052183 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,853 in 43 payments from 8 companies in 2025. Trend: 2023 $1,176 · 2024 $981 · 2025 $1,853

Food & beverage: $1,735Education: $119
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.6$590
Teva Pharmaceuticals USA, Inc.12$349
Neurocrine BioSciences, Inc.11$223
Otsuka America Pharmaceutical, Inc.4$215
Janssen Pharmaceuticals, Inc7$187
Axsome Therapeutics, Inc.1$123
Supernus Pharmaceuticals, Inc.1$101
ABBVIE INC.1$64

Products named: COBENFY, AUSTEDO XR, INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA, Auvelity, Qelbree, VRAYLAR.

Industry payments across ID — which companies pay providers there.